Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (21-30 of 318) with videos related to

Pageof 32
Sort By:
Gastroenterology|October 18, 2012
Insulin resistance and response to telaprevir plus pegylated interferon and ribavirin: a requiem for the HOMA score?Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2020
Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up?Francesca Colapietro, Alessio Aghemo
Gastroenterology|July 2, 2015
Will the Benefits of Treatment for Chronic Hepatitis C Be Retained in the Interferon-free Era?Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|June 17, 2021
Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right directionChiara Masetti, Alessio Aghemo
Gastroenterology|March 1, 2011
A rapid point-of-care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations?Alessio Aghemo, Massimo Colombo
Gastroenterology|November 26, 2009
Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an idealAlessio Aghemo, Massimo Colombo
Gastroenterology|August 25, 2010
Telaprevir for hepatitis C re-treatment: an open door on a long and winding roadAlessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
How to optimize HCV therapy in genotype 2 patientsEleonora Grassi, Alessio Aghemo
Gut|August 8, 2013
Treatment of patients with dual hepatitis B and C: a step in the right directionAlessio Aghemo, Massimo Colombo
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2014
Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patientsEnrico Galmozzi, Alessio Aghemo
Pageof 32

Showing results (21-30 of 318) with videos related to

Sort By:
Pageof 32
Gastroenterology|October 18, 2012
Insulin resistance and response to telaprevir plus pegylated interferon and ribavirin: a requiem for the HOMA score?Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2020
Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up?Francesca Colapietro, Alessio Aghemo
Gastroenterology|July 2, 2015
Will the Benefits of Treatment for Chronic Hepatitis C Be Retained in the Interferon-free Era?Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|June 17, 2021
Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right directionChiara Masetti, Alessio Aghemo
Gastroenterology|March 1, 2011
A rapid point-of-care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations?Alessio Aghemo, Massimo Colombo
Gastroenterology|November 26, 2009
Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an idealAlessio Aghemo, Massimo Colombo
Gastroenterology|August 25, 2010
Telaprevir for hepatitis C re-treatment: an open door on a long and winding roadAlessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
How to optimize HCV therapy in genotype 2 patientsEleonora Grassi, Alessio Aghemo
Gut|August 8, 2013
Treatment of patients with dual hepatitis B and C: a step in the right directionAlessio Aghemo, Massimo Colombo
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2014
Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patientsEnrico Galmozzi, Alessio Aghemo
Pageof 32